111 related articles for article (PubMed ID: 21960222)
1. Kinase inhibitor profiling using chemoproteomics.
Schirle M; Petrella EC; Brittain SM; Schwalb D; Harrington E; Cornella-Taracido I; Tallarico JA
Methods Mol Biol; 2012; 795():161-77. PubMed ID: 21960222
[TBL] [Abstract][Full Text] [Related]
2. Proteome-wide identification of staurosporine-binding kinases using capture compound mass spectrometry.
Fischer JJ; Graebner Neé Baessler OY; Dreger M
Methods Mol Biol; 2012; 795():135-47. PubMed ID: 21960220
[TBL] [Abstract][Full Text] [Related]
3. Affinity purification of proteins binding to kinase inhibitors immobilized on self-assembling monolayers.
Bantscheff M; Hobson S; Kuster B
Methods Mol Biol; 2012; 795():149-60. PubMed ID: 21960221
[TBL] [Abstract][Full Text] [Related]
4. Determination of kinase inhibitor potencies in cell extracts by competition binding assays and isobaric mass tags.
Hopf C; Eberhard D; Boesche M; Bastuck S; Dümpelfeld B; Bantscheff M
Methods Mol Biol; 2012; 803():141-55. PubMed ID: 22065223
[TBL] [Abstract][Full Text] [Related]
5. Chemoproteomic characterization of protein kinase inhibitors using immobilized ATP.
Duncan JS; Haystead TA; Litchfield DW
Methods Mol Biol; 2012; 795():119-34. PubMed ID: 21960219
[TBL] [Abstract][Full Text] [Related]
6. Measuring phosphorylation-specific changes in response to kinase inhibitors in mammalian cells using quantitative proteomics.
Ozlü N; Kirchner M; Steen JJ
Methods Mol Biol; 2012; 795():217-31. PubMed ID: 21960226
[TBL] [Abstract][Full Text] [Related]
7. Covalent cross-linking of kinases with their corresponding peptide substrates.
Statsuk AV; Shokat KM
Methods Mol Biol; 2012; 795():179-90. PubMed ID: 21960223
[TBL] [Abstract][Full Text] [Related]
8. A liquid chromatography/mass spectrometry-based method for the selection of ATP competitive kinase inhibitors.
Khandekar SS; Feng B; Yi T; Chen S; Laping N; Bramson N
J Biomol Screen; 2005 Aug; 10(5):447-55. PubMed ID: 16093554
[TBL] [Abstract][Full Text] [Related]
9. Affinity classification of kinase inhibitors by mass spectrometric methods and validation using standard IC(50) measurements.
Jecklin MC; Touboul D; Jain R; Toole EN; Tallarico J; Drueckes P; Ramage P; Zenobi R
Anal Chem; 2009 Jan; 81(1):408-19. PubMed ID: 19067573
[TBL] [Abstract][Full Text] [Related]
10. Acid elution and one-dimensional shotgun analysis on an Orbitrap mass spectrometer: an application to drug affinity chromatography.
Fernbach NV; Planyavsky M; Müller A; Breitwieser FP; Colinge J; Rix U; Bennett KL
J Proteome Res; 2009 Oct; 8(10):4753-65. PubMed ID: 19653696
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive identification of staurosporine-binding kinases in the hepatocyte cell line HepG2 using Capture Compound Mass Spectrometry (CCMS).
Fischer JJ; Graebner Baessler OY; Dalhoff C; Michaelis S; Schrey AK; Ungewiss J; Andrich K; Jeske D; Kroll F; Glinski M; Sefkow M; Dreger M; Koester H
J Proteome Res; 2010 Feb; 9(2):806-17. PubMed ID: 20028079
[TBL] [Abstract][Full Text] [Related]
12. Quantification of protein kinase activities by LC-MS.
Alcolea MP; Cutillas PR
Methods Mol Biol; 2010; 658():325-37. PubMed ID: 20839114
[TBL] [Abstract][Full Text] [Related]
13. An immuno-chemo-proteomics method for drug target deconvolution.
Saxena C; Zhen E; Higgs RE; Hale JE
J Proteome Res; 2008 Aug; 7(8):3490-7. PubMed ID: 18590316
[TBL] [Abstract][Full Text] [Related]
14. MALDI-TOF mass-spectrometry-based versatile method for the characterization of protein kinases.
Kondo N; Nishimura S
Chemistry; 2009; 15(6):1413-21. PubMed ID: 19115309
[TBL] [Abstract][Full Text] [Related]
15. Surface-plasmon-resonance-based chemical proteomics: efficient specific extraction and semiquantitative identification of cyclic nucleotide-binding proteins from cellular lysates by using a combination of surface plasmon resonance, sequential elution and liquid chromatography-tandem mass spectrometry.
Visser NF; Scholten A; van den Heuvel RH; Heck AJ
Chembiochem; 2007 Feb; 8(3):298-305. PubMed ID: 17206730
[TBL] [Abstract][Full Text] [Related]
16. Affinity Enrichment Chemoproteomics for Target Deconvolution and Selectivity Profiling.
Werner T; Steidel M; Eberl HC; Bantscheff M
Methods Mol Biol; 2021; 2228():237-252. PubMed ID: 33950495
[TBL] [Abstract][Full Text] [Related]
17. Affinity profiling of the cellular kinome for the nucleotide cofactors ATP, ADP, and GTP.
Becher I; Savitski MM; Savitski MF; Hopf C; Bantscheff M; Drewes G
ACS Chem Biol; 2013 Mar; 8(3):599-607. PubMed ID: 23215245
[TBL] [Abstract][Full Text] [Related]
18. Monitoring phosphoproteomic response to targeted kinase inhibitors using reverse-phase protein microarrays.
Lavezzari G; Lackner MR
Methods Mol Biol; 2012; 795():203-15. PubMed ID: 21960225
[TBL] [Abstract][Full Text] [Related]
19. Targeting cancer with small-molecular-weight kinase inhibitors.
Fabbro D; Cowan-Jacob SW; Möbitz H; Martiny-Baron G
Methods Mol Biol; 2012; 795():1-34. PubMed ID: 21960212
[TBL] [Abstract][Full Text] [Related]
20. Proteomic and biochemical analysis of 14-3-3-binding proteins during C2-ceramide-induced apoptosis.
Pozuelo-Rubio M
FEBS J; 2010 Aug; 277(16):3321-42. PubMed ID: 20618440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
